Ebola on the Move

Health officials report the first case of Ebola virus disease outside of Guinea, Liberia, and Sierra Leone. A 40-year-old man has died in Nigeria.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDC PUBLIC HEALTH IMAGE LIBRARYWith a fatality rate of up to 90 percent, Ebola is one of the most virulent and deadly viral diseases. An ongoing outbreak in Africa that has claimed the lives of more than 600 people since February appears to be on the move. Having already struck in Guinea, Liberia, and Sierra Leone, Ebola infection has now killed a 40-year-old man who traveled through a Lagos airport, health officials confirmed on Friday (July 25), marking “a new and alarming cross-border development in a disease that has spiralled into the world’s biggest epidemic, spread across three West African countries,” The Guardian reported.

“The national authority in Nigeria is working closely with WHO and partners to ensure that this incident case is contained at the source,” the World Health Organization (WHO) noted in a July 27 statement. Health officials are now monitoring individuals who may have had contact with the man who died.

Two American health-care workers in Liberia have tested positive for Ebola, USA Today and the Associated Press reported. One is symptomatic and in isolation; the other has not shown signs of the disease, Stephan Monroe, deputy director of US Centers for Disease Control and Prevention’s National Center for Emerging and Zoonotic Infectious Diseases, said during a press conference today.

“This is the largest Ebola outbreak in history,” said Monroe. The risk of transmission beyond West ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies